Resistencia a la terapia antirretroviral (TAR) en pacientes VIH/SIDA en fracaso terapéutico, Cali-Colombia

LM Agudelo-Rojas, MV Coral-Orbes… - Acta Médica …, 2019 - actamedicacolombiana.com
Introducción: la replicación del VIH y la utilización subóptima de antirretrovirales, se
relacionan directamente con la aparición de mutaciones de resistencias. El objetivo del …

[HTML][HTML] Resistencia a fármacos en pacientes en tratamiento antirretroviral, Cali, Colombia, 2008-2010

JL Martínez-Cajas, HF Mueses-Marín… - Biomédica, 2013 - scielo.org.co
Introducción. En Colombia se ha publicado poco sobre farmacorresistencia del VIH en
pacientes que reciben tratamiento antirretroviral. Las guías de VIH de Colombia de 2006, no …

Pooled HIV-1 RNA viral load testing for detection of antiretroviral treatment failure in Kenyan children

BH Chohan, K Tapia, M Merkel… - JAIDS Journal of …, 2013 - journals.lww.com
Background: Pooled viral load (VL) testing with 2 different testing strategies was evaluated
as a potential cost saving method to monitor antiretroviral therapy (ART) in HIV-infected …

Resistance considerations in sequencing of antiretroviral therapy in low-middle income countries with currently available options

A De Luca, M Prosperi, L Bracciale - Current Opinion in HIV and …, 2010 - journals.lww.com
Resistance considerations in sequencing of antiretroviral th... : Current Opinion in HIV and
AIDS Resistance considerations in sequencing of antiretroviral therapy in low-middle income …

Early versus deferred antiretroviral therapy in children in low-income and middle-income countries

T Puthanakit, T Bunupuradah - Current Opinion in HIV and AIDS, 2010 - journals.lww.com
The current trend is to move toward early treatment to reduce morbidity and mortality,
achieve immune recovery, normal growth, and development. Even though the antiretroviral …

[HTML][HTML] Long term impact of antiretroviral therapy-Can we end HIV epidemic, the goal beyond 2015

N Kumarasamy, R Pendse - Indian Journal of Medical Research, 2014 - journals.lww.com
Tuberculosis continues to be the major co-factor in HIV disease progression in HIV infected
persons12. The WHO has recommended isoniazid preventive therapy (IPT) which is being …

[HTML][HTML] Antiretroviral resistance following immunological monitoring in a resource-limited setting of western India: A cross-sectional study

SK Karade, SS Kulkarni, MV Ghate, AA Patil, R Londhe… - Plos one, 2017 - journals.plos.org
Background The free antiretroviral therapy (ART) program in India still relies on the clinico-
immunological monitoring for diagnosis of treatment failure. As the nucleoside reverse …

Clinical benefits and cost-effectiveness of laboratory monitoring strategies to guide antiretroviral treatment switching in India

KA Freedberg, N Kumarasamy, ED Borre… - AIDS research and …, 2018 - liebertpub.com
Current Indian guidelines recommend twice-annual CD4 testing to monitor first-line
antiretroviral therapy (ART), with a plasma HIV RNA test to confirm failure if CD4 declines …

Regional challenges in the prevention of human immunodeficiency virus drug resistance

C Godfrey, M Bobkova, C Boucher… - The Journal of …, 2017 - academic.oup.com
In diverse global regions with significant human immunodeficiency virus (HIV) burden,
programmatic, cultural, and provider-, patient-, and virus-related factors may result in HIV …

Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study

L Nicole, DA Cooper, D Russell, D Smith… - Sexual …, 2016 - CSIRO Publishing
Background: Integrase inhibitors (INSTI) are a newer class of antiretroviral (ARV) drugs that
offer additional treatment options for experienced patients. Our aim is to describe treatment …